GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
0.2379
+0.0227 (10.55%)
At close: Jan 14, 2026, 4:00 PM EST
0.2475
+0.0096 (4.04%)
Pre-market: Jan 15, 2026, 7:00 AM EST
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $3.32 million as of January 15, 2026. Its market cap has decreased by -52.70% in one year.
Market Cap
3.32M
Enterprise Value
-655.77K
1-Year Change
-52.70%
Ranking
Category
Stock Price
$0.24
Market Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.38M to $3.32M, a decrease of -86.94%. That is a compound annual growth rate of -52.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 3.00M | 20.06% |
| Dec 31, 2025 | 2.50M | -66.25% |
| Dec 31, 2024 | 7.40M | 325.43% |
| Dec 29, 2023 | 1.74M | -93.15% |
| Apr 24, 2023 | 25.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.49B |
| Johnson & Johnson | 514.75B |
| AbbVie | 390.15B |
| UnitedHealth Group | 302.49B |
| AstraZeneca | 291.77B |
| Novartis AG | 272.12B |
| Merck & Co. | 268.70B |
| Novo Nordisk | 265.30B |